Fagron Compounding Services is recalling approximately 92,470 bags of sterile injectable drugs, including norepinephrine Bitartrate and Vancomycin HCl. The recall was initiated because of a lack of sterility assurance after discovery that a blue break-off part of the administration port could detach. No incidents or injuries have been reported to date. These products were distributed nationwide to hospitals and healthcare facilities.
A detached part in the administration port can compromise the sterile seal of the IV bag, potentially leading to a lack of sterility and increasing the risk of serious infection for patients receiving these medications intravenously.
Recall #: D-0438-2026; Quantity: 25,260 bags
Recall #: D-0439-2026; Quantity: 5,140 bags
Recall #: D-0440-2026; Quantity: 34,260 bags
Recall #: D-0441-2026; Quantity: 16,130 bags
Recall #: D-0442-2026; Quantity: 11,680 bags
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.